Form D · Hedge Fund
Biomedical Offshore Value Fund, Ltd.
Grand Cayman, E9 · CIK 0001312877
Offering snapshot reported Dec 17, 2025 · SEC filing
- Reported sold
- $772M Indefinite offering
- Investors reported
- 73 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2011 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$771,974,062 → $772,302,554
- Reported investors92 → 73
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 17, 2025 | Amendment | $772,302,554 | $328,492vs Dec 18, 2024 | 73 | SEC filing |
| Dec 18, 2024 | Amendment | $771,974,062 | $768,357,897vs Feb 27, 2019 | 92 | SEC filing |
| Dec 19, 2023 | Amendment | $756,755,461 | $753,139,296vs Feb 27, 2019 | 95 | SEC filing |
| Dec 23, 2022 | Amendment | $738,303,062 | $734,686,897vs Feb 27, 2019 | 76 | SEC filing |
| Dec 20, 2021 | Amendment | $665,384,399 | $631,951,512vs Dec 20, 2021 | 27 | SEC filing |
| Dec 20, 2021 | Amendment | $33,432,887 | -$598,518,625vs Dec 17, 2020 | 27 | SEC filing |
| Dec 17, 2020 | Amendment | $631,951,512 | $628,335,347vs Feb 27, 2019 | 53 | SEC filing |
| Feb 27, 2019 | Initial | $3,616,165 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-333737
Source: Form D, filed Dec 17, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
BIOMEDICAL OFFSHORE VALUE FUND, LTD.
Investment adviser: GREAT POINT PARTNERS, LLC
- Gross asset value
- $179M
- Beneficial owners
- 62
- ADV minimum commitment
- $1M
Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- Yes
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
KPMG
PCAOB 1323
JEFFERIES LLC
SEC 8-15074
NATIONAL FINANCIAL SERVICES LLC
SEC 8-26740
THE NORTHERN TRUST INTERNATIONAL BANKING CORPORATION
LEI 54930042DBMRRWU1QM80
JEFFERIES LLC
CRD 2347 · SEC 8-15074
NATIONAL FINANCIAL SERVICES LLC
CRD 13041 · SEC 8-26740
Filing source
Form ADV 2069272 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-7553484342
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Great Point Partners, Llc | Promoter |
| Charl Grobler | Director |
| Jeffrey Jay | Director, Promoter |
| Alan Kelly | Director |
| David Kroin | Executive |
| Riyaz Nooruddin | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Grand Cayman, E9, KY1-9005